The CDC will distribute 77,000 additional doses of Beyfortus, a respiratory syncytial virus (RSV) drug from Sanofi and AstraZeneca, to deal with shortages and unprecedented demand that has left pediatricians and hospitals struggling to stock the immunization. The doses will be distributed to physicians, hospitals, and through the Vaccines for Children Program.
Sky News quiz of the year: Test your knowledge of 2025
From the election of a new pope to a singer blasting off into space and a president giving a huge body of water a new
